Geographic Atrophy
Geographic Atrophy (GA) is a progressive eye disease that causes the gradual loss of retinal cells, leading to vision loss, particularly in older adults. It is a form of age-related macular degeneration (AMD).
We are examining the long-term safety and tolerability of JNJ-81201887 for people with geographic atrophy from age-related macular degeneration. This study follows participants from earlier trials to gather more information.
Health conditions and diseases that the clinical trial is designed to study and treat.
Geographic Atrophy (GA) is a progressive eye disease that causes the gradual loss of retinal cells, leading to vision loss, particularly in older adults. It is a form of age-related macular degeneration (AMD).
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.